Evidence map›Paper›PMID 34702254›Full record

ArticleCancer cell international2021

Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer.

Fangfang Huang, Yushi Zheng, Xiaoling Li, Hui Luo, Lianxiang Luo

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Recent progress of ferroptosis in cancers and drug discovery.Asian journal of pharmaceutical sciences · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Journal of gastrointestinal oncology · 2023
    Article
  15. Article
  16. Article
  17. Silencing of mAmerican journal of cancer research · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fangfang HuangGuangdong Medical University, Zhanjiang, 524023, Guangdong, China.
Yushi ZhengThe First Clinical College, Guangdong Medical University, Zhanjiang, 524023, Guangdong, China.
Xiaoling LiExperimental Animal Center, Guangdong Medical University, Zhanjiang, 524023, Guangdong, China.
Hui LuoThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, 524023, Guangdong, China. luohui@gdmu.edu.cn.
Lianxiang LuoThe Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, 524023, Guangdong, China. luolianxiang321@gdmu.edu.cn.ORCID http://orcid.org/0000-0002-3391-9713
Guangdong Medical College · CN

Funding

administration of traditional chinese medicine of guangdong province 20201180;20211223basic and applied basic research program of guangdong province 2019A1515110201discipline construction project of guangdong medical university 4SG21004Gfund of southern marine science and engineering guangdong laboratory (zhanjiang) ZJW-2019-007program of department of natural resources of guangdong province GDNRC [2020]038 and [2021]53science and technology special project of zhanjiang 2019A01009the phd start-up fund of guangdong medical university B2019016
6 · The paper itself

Abstract

backgroundFerroptosis is a newly discovered mode of cell death distinct from apoptosis and necrosis, and its activation contributes to anticancer therapy in a variety of cancers. However, the prognostic value of ferroptosis-related genes in non-small cell lung cancer (NSCLC) remains to be further investigated.

methodsNSCLC transcriptome mRNA-seq data set and corresponding clinical data set were downloaded from the Cancer Genome Atlas (TCGA). Then, bioinformatics approaches were subsequently employed to identify potential prognostic markers. Finally, the effects of candidate markers on NSCLC cell proliferation, migration, and ferroptosis were assessed by CCK8, colony formation, wound-healing assay, and functional assays related to ferroptosis.

resultsA total of 37 common differentially expressed genes were screened based TCGA database. Six overall survival associated genes (ENPP2, ULK1, CP, LURAP1L, HIC1, AKR1C1) were selected to build survival model, of which hub gene AKR1C1 was with high expression and low ferroptosis level in NSCLC tumor. Further research showed that AKR1C1 was related with many pathways involved in the process of ferroptosis and associated with diverse cancer-infiltrating immune cells. Moreover, the results of in vitro experiments indicated that the expression of AKR1C1 was upregulated in NSCLC cell lines, and silencing AKR1C1 can inhibit the proliferation and migration of NSCLC cells and promote the occurrence of ferroptosis.

conclusionsOur study revealed the potential role of ferroptosis-related gene AKR1C1 in NSCLC, which can be used for prognostic prediction in NSCLC.

Indexed as

AKR1C1Bioinformatics analysisBiomarkerFerroptosisNon-small cell lung cancer

Identifiers

PMID34702254
PMCPMC8549233
OpenAlexW3186673077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.